Asenti uses AI to review construction project documents and detect errors, inconsistencies, and missing information before they cause problems on site. By improving quality control early in the process, we help construction teams reduce costly mistakes, avoid rework, and improve coordination across disciplines.

We are Starstuff. We are a compact team split between tech and business, building the world’s first AI-powered social platform for playable content. Think TikTok meets Roblox, powered by AI, and shaped by Gen Z and Gen Alpha. We are inventing a new content format: instant, social, playable creation — at the speed of memes. We have caught lightning in a bottle: 1.5M+ users, 80K+ creators, and 35M+ views on social. Now, we need to turn this viral explosion into a stable, scalable platform without slowing down innovation.

Gire er en Norsk virksomhed, der siden starten har oplevet fantastisk vækst og har nu været aktiv i Danmark i mere end 3 år. Vores opgave er at hente og levere biler. Vi forbinder virksomheder, der har brug for at få en bil kørt fra A til B, via en enkel og nyskabende platform. Bilerne transporteres på hjul fra punkt A til B inden for aftalte tider, fuldt forsikret og til faste priser.

The Problem Most workplaces struggle with high sick leave — and the root causes are rarely acute injuries or illness. They are lifestyle-driven issues: • fatigue and low energy • stress and mental strain • poor sleep • musculoskeletal pain • unhealthy habits • lack of support These problems build up over time, and employees try to handle them alone. But people don’t change their health on their own — and employers don’t have the tools or competency to help them. The result? High sick leave costs, reduced productivity, and employees who are stuck in patterns they can’t break. Why it matters Sick leave is one of the biggest hidden costs in business. A single employee on sick leave costs on average 65 200 kr per year — and 20% of employees account for 80% of the total. Most of these cases are preventable with the right support. At the same time, people want help: 85% prefer guidance from a qualified professional rather than trying to solve health challenges alone. ABEL’s Role ABEL solves this gap. We connect employees with qualified health coaches who follow them closely over time — mentally, physically, and socially. Through structured guidance and our digital platform, we help people make sustainable lifestyle changes that reduce sick leave and increase wellbeing. The impact: Employees get better health. Companies save money. Society reduces the burden of preventable illness.

Celto blev startet med ønsket om at give mennesker nem adgang til indsigt i deres helbred – ikke gennem tilfældige råd, men gennem præcise data fra blodprøver. Vi tror på forebyggelse, optimering og langsigtet sundhed, hvor livskvalitet er lige så vigtigt som levetid. Navnet Celto udspringer af ordet celle, kroppens mindste enhed og fundamentet for alt liv. Det afspejler vores tilgang: små, målrettede målinger og justeringer kan skabe store resultater, når man arbejder systematisk og ser helheden. Celto hjælper dig med at forstå og optimere dit helbred gennem præcise sundhedstjek, data og personlig indsigt samlet ét sted.

PharosBio is building an autonomous AI scientist—a platform and APIs that help biopharma and research teams reduce R&D risk by turning fragmented evidence into decisions across discovery and translation. The problem Despite billions spent on R&D, the research ecosystem runs on incomplete, siloed insight. Around 90% of drug candidates still fail in the clinic, wasting time and capital and delaying therapies for patients. This affects 4.5 million scientists across pharma, biotech, and academia who must constantly decide what to study, why it matters, and whether to proceed—with evidence that’s scattered and stale. Our solution We’re building the first agentic AI built for life sciences: a system that plans, reads, reasons, and writes like a tireless collaborator, and plugs into existing workflows via APIs. What it does • Target discovery & repurposing: surfaces novel targets and repositioning opportunities from literature and data; ranks by mechanism and evidence strength. • Translational go/no-go: aggregates preclinical and clinical signals to support milestone decisions with transparent rationales. • Scientific writing copilot: drafts systematic reviews, grant sections, IND-supporting summaries, and patent landscape briefs with citations. How it fits • Platform + APIs integrate with existing tools and pipelines. • Evidence-first UX: every recommendation is linked to sources; uncertainty is quantified. • Autonomy with control: agents run end-to-end tasks, while scientists supervise, edit, and approve. Outcomes • Faster time to insight, • Fewer dead-ends, • Higher confidence at each stage from early discovery to translation. Our motivation We’re expats who fell in love with Denmark’s research culture and collaborative ecosystem. We started PharosBio because agentic AI is powerful but under-applied where it matters most—healthcare, research, and biotech. Watching promising ideas stall for lack of clear evidence lit the spark: we want to equip every scientist with an always-on partner, so more therapies reach patients - us and our loved ones!

Angry Camel AB is a Swedish-based food technology company specializing in plant-based protein development for industrial applications. Our flagship innovation, ChickBumin®, is a high-performance chickpea protein powder engineered to replace egg white and albumin in large-scale food production. Designed with functionality, cost-efficiency, and clean-label compliance in mind, ChickBumin® supports emulsification, foaming, and binding — without allergens, GMOs, or synthetic additives.

HubBroker ApS is a leading provider of cloud-based EDI software solutions, helping businesses automate and streamline data exchange across ERP systems, trading partners, and digital platforms. Through our robust Integration Platform as a Service (iPaaS), we enable real-time connectivity between applications such as Microsoft Dynamics 365, SAP, e-conomic, Visma, Shopify, WooCommerce, and Amazon. Our scalable, industry-neutral platform simplifies complex B2B workflows by automating orders, invoices, shipping notices, and other essential documents, reducing manual tasks, minimizing errors, and improving operational efficiency. Serving a wide range of industries, including retail, manufacturing, wholesale, and logistics, HubBroker delivers tailored integration software that supports digital transformation and long-term business growth. With a strong focus on security, flexibility, and customer success, we are a trusted partner for businesses seeking the best EDI software solutions.

ESEBA, a deep tech startup from DTU, transforms low-quality textile waste into MDF boards without binders or formaldehyde. We offer a sustainable, non-toxic alternative to traditional wood-based panels. Textile waste is a massive and growing problem in Europe – less than 1% is recycled into new products, and most ends up incinerated. At the same time, formaldehyde regulations are tightening, and deforestation pressures are increasing demand for alternatives to virgin wood. ESEBA’s mission is to enable local, circular board production through a scalable, plug-and-produce production line for furniture manufacturers.

Comeply is a pioneering SaaS compliance management platform designed specifically for organizations navigating the complex regulatory landscapes of highly regulated industries, with particular expertise in pharmaceutical compliance. We transform how companies understand, monitor, and maintain their compliance posture by delivering real-time regulatory intelligence coupled with powerful analytical capabilities. Our platform continuously scans, processes, and interprets regulatory changes from authoritative sources including ICH, FDA, EMA, eCFR, and pharmacopoeias, creating an always-current compliance knowledge base. What sets Comeply apart is our unique ability to automatically compare regulatory requirements against a company's internal quality management documentation, identifying compliance gaps and potential risk areas before they become issues. We provide dynamic compliance scoring that quantifies and visualizes compliance status across various regulatory domains such as safety, site oversight, and quality management, enabling leadership to make informed decisions based on clear compliance metrics. When regulations evolve, our sophisticated delta analysis highlights specific differences between previous and updated requirements, with targeted notifications that connect directly to the departments and processes affected within your organization. Beyond mere notification, Comeply delivers contextual understanding of regulatory changes, showing precisely how they impact your current compliance position and what actions may be required. By automating the labor-intensive processes of regulatory monitoring and interpretation, we enable compliance and quality assurance teams to shift from reactive document management to strategic compliance leadership, reducing compliance risk while simultaneously cutting monitoring costs by up to 80%. For pharmaceutical companies and other organizations where regulatory excellence is non-negotiable, Comeply transforms compliance from an operational burden into a sustainable competitive advantage.

ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.

We help internationals in Denmark close the gap to securing jobs by building skills, networks, and opportunities. Our vision is to level the playing field by providing practical tools, a supportive community, and creating direct connections with potential employers to help internationals succeed in the Danish job market.

We develop a software product for energy companies and wind developers to guide the end-of-life phase of wind farms. Our mission is to accelerate wind energy renewal and ensure no components end up in landfill. ReWind began as an internal project in DNV, but has since spun out into an independent, fast-growing company since launching our product.

We're redefining the future of Capital Markets with our AI-enhanced automation platform, that replaces manual, static processes and siloed knowledge pools with dynamic, data-driven, and digital automation workflows that scale expertise and enhance productivity. We're starting by automating essential Capital Markets technology change, accelerating delivery, reducing cost, and minimising operational risk.

We offer a clinically validated treatment tool and concept for efficient childhood obesity treatment in a clinical setting. With objective data collection as a basis, gathered in the comfort of the families own homes, we automate and display reports to health care professionals in order to prioritize patient intervention at the right time. This enables clinics to double treatment effect with half the resources compared to traditional care.